Olivier Zitoun
Chief Executive Officer at Eveo, Inc.
Profile
Olivier Zitoun is the founder and current Chief Executive Officer of Eveo, Inc. which is founded in 1999.
He previously worked as the Chief Technology Officer at AEON Biopharma Sub, Inc.
Olivier Zitoun active positions
| Companies | Position | Start |
|---|---|---|
Eveo, Inc.
 Eveo, Inc. Advertising/Marketing ServicesCommercial Services Eveo, Inc. operates as a digital healthcare agency. Its services include insights and planning, include competitive mining, customer research, behavioral and trend analytics and brand planning, imaginativeness, include branding, conceptualizing, visual design and data visualization, social listening, point of care and sales aids, technology and innovation, include platform development, emerging media and system integration. It clients include Abbott, abbvie, Actavis, Amgen, Celgene, tpi and genzyme. The company was founded by Olivier Zitoun and Shadi Mahassel in 1999 and is headquartered in San Francisco, CA. | Chief Executive Officer | 1998-12-31 |
Former positions of Olivier Zitoun
| Companies | Position | End |
|---|---|---|
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Eveo, Inc.
Eveo, Inc. Advertising/Marketing ServicesCommercial Services Eveo, Inc. operates as a digital healthcare agency. Its services include insights and planning, include competitive mining, customer research, behavioral and trend analytics and brand planning, imaginativeness, include branding, conceptualizing, visual design and data visualization, social listening, point of care and sales aids, technology and innovation, include platform development, emerging media and system integration. It clients include Abbott, abbvie, Actavis, Amgen, Celgene, tpi and genzyme. The company was founded by Olivier Zitoun and Shadi Mahassel in 1999 and is headquartered in San Francisco, CA. | Commercial Services |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Health Technology |
- Stock Market
- Insiders
- Olivier Zitoun
